Skip to main content
Livermore
Livermore
ZHEN

Marshall Wace, LLP

SEC CIK
0001318757
Latest filing
Aug 13, 2026

TNDM holding history

Tandem Diabetes Care Inc in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TNDM overviewAll 13F holders of TNDMFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
15
Since Q1 2021
Holdings of TNDM by Marshall Wace, LLP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,442,472−100.0%Sold outHolders
Q1 20261,442,472$27.7M<0.1%+566,941+64.8%AddedHolders
Q4 2025875,531$19.2M<0.1%+875,531NewHolders
Q2 20250$00.0%−70,399−100.0%Sold outHolders
Q1 202570,399$1.35M<0.1%−880,549−92.6%ReducedHolders
Q4 2024950,948$34.3M<0.1%+137,354+16.9%AddedHolders
Q3 2024813,594$34.5M<0.1%+289,201+55.1%AddedHolders
Q2 2024524,393$21.1M<0.1%−2,595,981−83.2%ReducedHolders
Q1 20243,120,374$110.5M0.2%+2,768,459+786.7%AddedHolders
Q4 2023351,915$10.4M<0.1%+172,875+96.6%AddedHolders
Q3 2023179,040$3.72M<0.1%−478,121−72.8%ReducedHolders
Q2 2023657,161$16.1M<0.1%+657,161NewHolders
Q1 20230$00.0%−881,307−100.0%Sold outHolders
Q4 2022881,307$39.6M0.1%+881,307NewHolders
Q2 20220$00.0%−24,703−100.0%Sold outHolders
Q1 202224,703$2.87M<0.1%−55,673−69.3%ReducedHolders
Q4 202180,376$12.1M<0.1%+64,572+408.6%AddedHolders
Q3 202115,804$1.89M<0.1%+15,804NewHolders
Q2 20210$00.0%−4,795−100.0%Sold outHolders
Q1 20214,795$424.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.